Serum concentrations of MIP-1 α and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria

Clinical Immunology and Immunopathology

Volumn 76, Issue 1, 1995, Pages 32-36

  Burgmann, H ^a   Hollenstein, U ^a   Wenisch, C ^a   Thalhammer, F ^a   Looareesuwan, S ^a   Graninger, W ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0029028882     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1995.1084     Document Type: Article

References (48)

1. Schall, T. J., Bacon, K., Camp, R. D., Kaspari, J. W., and Goeddel, D. V., Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177, 1821-1826, 1993.
2. Sherry, B., Tekamp Olson, P., Gallegos, C, Bauer, D., Davatelis, G., Wolpe, S. D., Masiarz, F., Coit, D., and Cerami, A., Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 beta. J. Exp. Med. 168, 2251-2259, 1988.
3. Schall, T. J., Bacon, K, Toy, K. J., and Goeddel, D. V., Selective attraction of monocytes and T lymphocytes of the memory phe-notype by cytokine RANTES. Nature 347, 669-671, 1990.
4. Fahey, T. J., Tracey, K. J., Tekamp-Ohlson, P., Cousens, L. S., Jones, W. S., Shires, G. T., Cerami, A., and Sherry, B., Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol. 148, 2764, 1992.
5. Alam, R., Forsythe, P. A., Stafford, S., Lett Brown, M. A., and Grant, J. A., Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J. Exp. Med. 176, 781-786, 1992.
6. Rot, A., Krieger, M., Brunner, T., Bischoff, S. C., Schall, T. J., and Dahinden, C. A., RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176, 1489-1495, 1992.
7. Taub, D.D., Conlon, K., Lloyd, A. R., Oppenheim, J. J., and Kelvin, D. J., Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 260, 355-358, 1993.
8. Standiford, T. J., Rolfe, M. W., Kunkel, S. L., Lynch, J. P., Burdick, M. D., Gilbert, A. R., Orringer, M. B., Whyte, R. I., and Strieter, R. M., Macrophage inflammatory protein-1 alpha expression in interstitial lung disease. J. Immunol. 151, 2852-2863, 1993.
9. Gao, J. L., Kuhns, D. B., Tiffany, H. L., Mc Dermott, D., Li, X., Francke, U., and Murphy, P. M., Structure and functional expression of the human macrophage inflammatory protein 1 al-pha/RANTES receptor. J. Exp. Med. 177, 1421-1427, 1993.
10. Vogels, M. T., Lindley, I. J., Curfs, J. H., Eling, W. M., and van der Meer, J. W., Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob. Agents Chemother. 37, 276-280, 1993.
11. Marty, C, Misset, B., Tamion, F., Fitting, C, Carlet, J., and Cavaillon, J. M., Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit. Care Med. 22, 673-679, 1994.
12. Eckmann, L., Kagnoff, M. F., and Fierer, J., Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect. Immun. 61, 4569-4574, 1993.
13. Baggiolini, M., and Clark Lewis, I., Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 307, 97-101, 1992.
14. Neote, K, Di Gregorio, D., Mak, J. Y., Horuk, R., and Schall, T. J., Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72, 415-425, 1993.
15. Friedland, J. S., Suputtamongkol, Y., Remick, D. G., Chaowagul, W., Strieter, R. M., Kunkel, S. L., White, N. J., and Griffin, G. E., Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 m RNA levels during septicemic and localized Pseudomonas pseudoma-llei infection. Infect. Immun. 60, 2402-2408, 1992.
16. Maciejewski, J. P., Liu, J. M., Green, S. W., Walsh, C. E., Plumb, M., Pragnell, I. B., and Young, N. S., Expression of stem cell inhibitor (SCI) gene in patients with bone marrow failure. Exp. Hematol. 20, 1112-1117, 1992.
17. Lord, B. I., Heyworth, C. M., and Woolford, L. B., Macrophage inflammatory protein: Its characteristics, biological properties and role in the regulation of haemopoesis. Int. J. Hematol. 57, 197-206, 1993.
18. Graham, G. J., Wright, E. G., Hewick, R., Wolpe, S. D., Wilkie, N. M., Donaldson, D., Lorimore, S., and Pragnell, I. B., Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 344, 442-444, 1990.
19. Broxmeyer, H. E., Sherry, B., Lu, L., Cooper, S., Oh, K. O., Tekamp Olson, P., Kwon, B. S., and Cerami, A., Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells. Blood 76, 1110-1116, 1990.
20. Graham, G. J., and Pragnell, I. B., SCI/MIP-1 alpha: A potent stem cell inhibitor with potential roles in development. Deu. Biol. 151, 377-381, 1992.
21. Harpaz, R., Edelmann, R., Wassermann, S. S., Levine, M. M., Davis, J. R., and Sztein, M. B., Serum cytokine profiles in experimental human malaria. J. Clin. Invest. 90, 515-523, 1992.
22. Kern, P., Hemmer, C. J., Gallati, H., Neifer, S., Kremsner, P., Dietrich, M., and Porzsolt, F., Soluable tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J. Infect. Dis. 166, 930-934, 1992.
23. Kern, P., Hemmer, C. J., Van Damme, J., Grusss, H. J., and Dietrich, M., Elevated tumor necrosis factor alpha and interleu-kin-6 serum levels as markers for complicated Plasmodium fal-ciparum malaria. Am. J. Med. 87, 139-143, 1989.
24. Jakobsen, P. H., Morris Jones, S., Theander, T. G., Hviid, L., Hansen, M. B., Bendtzen, K., Ridley, R. G., and Greenwood, B. M., Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria. Clin. Exp. Immunol. 96, 98-103, 1994.
25. Ringwald, P., Peyron, F., Lepers, J. P., Rabarison, P., Rakoto-Malala, C, Razanamparany, M., Rabodonirina, M., Roux, J., and Le Bras, J., Parasite virulence factors during falciparum malaria: Rosetting, cytoadherence, and modulation of cytoadher-ence by cytokines. Infect. Immun. 61, 5198-5204, 1993.
26. Dormer, P., Dietrich, P., Kern, P., and Horstmann, R. D., Ineffective erythropoiesis in acute human falciparum malaria. Blut 46, 279-288, 1983.
27. Looaresuwan, S., Merry, A. H., Phillips, R. E., Pleehachinda, R., Wattanagoon, Y., Ho, M., Charoenlarp, P., Warrell, D. A., and Weatherall, D., Reduced erythrocyte survival following clearence of malarial parasitemia in Thai patients. Br. J. Hematol. 67, 473-478, 1987.
28. Abdalla, S. H., Hematopoiesis in human malaria. Blood Cells 16, 401-416, 1990.
29. Weatherall, D. J., and Abdalla, S., The anaemia of Plasmodium falciparum malaria. Br. Med. Bull. 38, 147-151, 1982.
30. Yap, G. S., and Stevenson, M. M., Inhibition of in vitro erythropoiesis by soluable mediators in plasmodium chabaudi AS malaria: Lack of a major role for Interleukin 1, tumor necrosis factor alpha, and gamma Interferon. Infect. Immun. 62, 357-362, 1994.
31. Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans. R. Soc. Trop. Med. Hyg. 84(Suppl. 2), 1-65, 1990.
32. de Kossodo, S., and Grau, G. E., Profiles of cytokine production in relation with susceptibility to cerebral malaria. J. Immunol. 151, 4811-4820, 1993.
33. Mshana, R. N., Boulandi, J., Mshana, N. M., Mayombo, J., and Mendome, G., Cytokines in the pathogenesis of malaria: Levels of IL-1 beta, IL-4, IL-6, TNF-alpha and IFN-gamma in plasma of healthy individuals and malaria patients in a holoendemic area. J. Clin. Lab. Immunol. 34, 131-139, 1991.
34. Grau, G. E., Bieler, G., Pointaire, P., de Kossodo, S., Tacchini Cotier, F., Vassalli, P., Piguet, P. F., and Lambert, P. H., Significance of cytokine production and adhesion molecules in malarial immunopathology. Immunol. Lett. 25, 189-194, 1990.
35. de Kossodo, S., and Grau, G. E., Role of cytokines and adhesion molecules in malaria immunopathology. Stem. Cells Dayt. 11, 41-48, 1993.
36. Grau, G. E., Essential role of tumor necrosis factor and other cytokines in the pathogenesis of cerebral malaria: experimental and clinical studies. Verh. K. Acad. Geneeskd. Belg. 54, 155-175, 1992.
37. Molyneux, M. E., Engelmann, H., Taylor, T. E., Wirima, J. J., Aderka, D., Wallach, D., and Grau, G. E., Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. Cytokine 5, 604-609, 1993.
38. Kasama, T., Strieter, R. M., Standiford, T. J., Burdick, M. D., and Kunkel, S. L., Expression and regulation of human neutro-phil-derived macrophage inflammatory protein 1 alpha. J. Exp. Med. 178, 63-72, 1993.
39. Christman, J. W., Blackwell, T. R., Cowan, H. B., Shepherd, V. L., and Rinaldo, J. E., Endotoxin induces the expression of macrophage inflammatory protein 1 alpha m RNA by rat alveolar and bone marrow-derived macrophages. Am. J. Respir. Cell Mol. Biol. 7, 455-461, 1992.
40. Sheron, N., and Williams, R., IL-8 as a circulating cytokine: Induction by recombinant tumour necrosis factor-alpha. Clin. Exp. Immunol. 89, 100-103, 1992.
41. Waage, A., and Steinshamn, S., Cytokine mediators of septic infections in the normal and granulocytopenic host. Eur. J. Hae-maiol. 50, 243-249, 1993.
42. Horuk, R., The interleukin-8-receptor family: From chemokines to malaria. Immunol. Today 15, 169-174, 1994.
43. Horuk, R., Chitnis, C. E., Darbonne, W. C, Colby, T. J., Rybicki, A., Hadley, T. J., and Miller, L. H., A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor. Science 261, 1182-1184, 1993.
44. Lukacs, N. W., Kunkel, S. L., Strieter, R. M., Warmington, K, and Chensue, S. W., The role of macrophage inflammatory protein 1 alpha in Schistosoma monsoni egg-induced granuloma-tous inflammation. J. Exp. Med. 177, 1551-1559, 1993.
45. Eaves, C. J., Cashman, J. D., Wolpe, S. D., and Eaves, A. C., Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells. Proc. Nati. Acad. Sci. USA 90, 12015-12019, 1993.
46. Lord, B. I., Heyworth, C. M., and Woolford, L. B., Macrophage inflammatory protein: Its characteristics, biological properties and role in the regulation of haemopoiesis. Int. J. Hematol. 57, 197-206, 1993.
47. Verfaillie, C. M., Catanzarro, P. M., and Li, W. N., Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J. Exp. Med. 179, 643-649, 1994.
48. Phillips, R. E., Looareesuwan, S., Warrell, D. A., Lee, S. H., Karbwang, J., Warrell, M. J., White, N. J., Swasdichai, C., and Weatherall, D. J., The importance of anaemia in cerebral and uncomplicated falciparum malaria: Role of complications, dyserythropoiesis and iron sequestration. Q. J. Med. 58, 305-323, 1986.